Manipal Hospitals
| インド | トルコ | オーストリア | |
| 肺高血圧症幹細胞治療 | から $8,500 | から $12,000 | から $55,000 |
| LDLアフェレーシス | から $1,400 | から $1,650 | - |
Bookimedは肺高血圧症治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。肺高血圧症治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。肺高血圧症治療の旅路でお一人になることはありません。
For pulmonary hypertension in India, you should consult a specialized pulmonologist or cardiologist. Ideally, choose a specialist focused on pulmonary vascular diseases at a JCI-accredited tertiary center. These experts manage the complex interaction between your heart and lungs through advanced diagnostic testing.
Bookimed Expert Insight: While India has over 90 specialized clinics, Global Hospital Chennai stands out for advanced cases. It is credited with the first successful lung and combined heart-kidney transplant in the country. This level of surgical expertise is rare. It indicates a facility capable of handling the most severe pulmonary vascular complications.
Patient Consensus: Patients emphasize starting with a pulmonologist for the initial workup. They note that choosing a large multispecialty hospital ensures all necessary imaging and specialists are in one location.
Right heart catheterization is the definitive test used by Indian hospitals to confirm pulmonary hypertension. This invasive procedure directly measures blood pressure inside the pulmonary arteries. Indian clinicians consider it the gold standard. It is required to establish a formal diagnosis before starting intensive therapy.
Bookimed Expert Insight: While India hosts 92 clinics for this condition, large centers like Global Hospital Chennai and Manipal Hospitals offer superior diagnostic depth. These facilities maintain specialized pulmonology departments alongside high-volume cardiology wings. This is vital because RHC results must be paired with lung function tests and high-resolution imaging to identify the underlying cause. Choosing a center with both National Accreditation Board for Hospitals and Healthcare Providers (NABH) and advanced pulmonary labs ensures your definitive test results are accurate.
Patient Consensus: Patients emphasize that an echocardiogram is just the first step. They note that a diagnosis is not actually final until the right heart catheterization is performed.
India provides various targeted medications for pulmonary arterial hypertension including PDE-5 inhibitors and endothelin receptor antagonists. Local pharmaceutical manufacturing ensures advanced therapies like sildenafil and ambrisentan are accessible. Most treatments are available through tertiary cardiology and pulmonology centers like Global Hospital Chennai and Manipal Hospitals.
Bookimed Expert Insight: Patients should prioritize tertiary facilities like Global Hospital Chennai which ranks among the worlds best. These high-volume centers handle over 80,000 patients annually and perform specialized lung transplants. Their internal pharmacies stabilize access to newer therapies like macitentan which are harder to find in outpatient clinics.
Patient Consensus: Patients note that sildenafil is the most accessible option due to widespread generic availability. Many emphasize that advanced combination therapies are best managed through specialist hospital pharmacies to ensure consistent stock.
Advanced prostacyclin analogues like Epoprostenol and Treprostinil are not locally manufactured or marketed in India. Patients with severe pulmonary hypertension can legally import these drugs for personal use through CDSCO Form 12A. Locally available oral options like Selexipag provide strong receptor-targeted therapy for advanced cases.
Bookimed Expert Insight: While parenteral prostacyclins are not sold in local pharmacies, India represents a global hub for pulmonary innovation. Global Hospital Chennai performed the first minimally invasive lung transplant in India. This suggests that for end-stage cases where medication limits are reached, Indian centers offer surgical alternatives that may be more sustainable than long-term drug imports.
Patient Consensus: Patients note that while advanced drugs exist in principle, the logistics of continuous infusion and catheter care are best managed at major metropolitan hospitals. Many emphasize that getting a specialized evaluation at a high-volume center is the first step toward accessing these restricted therapies.
Top Indian hospitals provide advanced interventions like balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic disease. Tertiary centers also offer bilateral lung transplantation for end-stage cases. JCI-accredited facilities utilize specialized catheterization labs to perform life-saving shunts and atrial septostomy for right-side heart decompression.
Bookimed Expert Insight: Data from leading facilities like Global Hospital Chennai shows a high concentration of expertise in complex thoracic procedures. This center achieved a national milestone by performing the first minimally invasive lung transplant in India. Patients seeking advanced surgical relief should prioritize clinics with multidisciplinary pulmonary hypertension teams. These high-volume centers, which serve up to 80,000 patients annually, often provide the necessary specialized imaging required for transplant and surgery eligibility.
Patient Consensus: Patients emphasize the need for early referral to high-volume centers to reduce surgical risks. Many note that choosing between surgery or balloon interventions depends heavily on where clots are located in the anatomy.
Top centers for pulmonary hypertension in India include JCI-accredited facilities like BLK Super Speciality Hospital and NABH-certified Medanta Hospital. These institutions feature multidisciplinary teams combining cardiology and pulmonology. They utilize advanced diagnostics like right heart catheterization and specialized pulmonary imaging to manage complex vascular diseases.
Bookimed Expert Insight: Patient data suggests looking beyond general cardiology departments to clinics with specific pulmonary vascular experience. Global Hospital Chennai stands out because it treats 80,000 patients annually and pioneered minimally invasive lung transplants in India. This high volume often correlates with better outcomes for rare, complex conditions like pulmonary hypertension.
Patient Consensus: Patients note it is vital to choose large tertiary centers that can coordinate cardiology and pulmonology care under one roof. They recommend bringing all previous echo and CT reports to your first visit to speed up the treatment process.
Pulmonary hypertension is generally a chronic condition without a universal cure. However, specialized Indian centers can fully reverse specific types. Success depends on treating underlying causes like heart defects or chronic blood clots using surgery. Advanced therapies in India focus on symptom control and lifespan extension.
Bookimed Expert Insight: While most clinics focus on management, Global Hospital Chennai stands out for complex cases. It performed Indias first minimally invasive lung and combined heart-kidney transplants. For patients with treatment-resistant hypertension, this advanced surgical capability is a critical safety net. High-volume centers like Manipal Hospitals serve 2,000,000 patients annually, ensuring deep experience in diagnostic accuracy.
Patient Consensus: Patients note that while a full cure is rare, symptoms improve significantly with early care. Many emphasize the need to find specialists who identify the exact cause before starting treatment.
Indian surgical centres report high success rates for pulmonary hypertension. This is when treating structural causes like atrial septal defects. Specialised hospitals in Chennai and Delhi perform complex lung and heart-lung transplants. International registries indicate roughly 50% of double lung transplant patients survive beyond 7.8 years.
Bookimed Expert Insight: Many associate pulmonary hypertension only with chronic medication. However, Indian centres like Global Hospital Chennai and Dr. Rela Institute specialise in high-volume organ transplants. Global Hospital Chennai reports performing 18,000 operations annually. This volume is critical for success in rare procedures like heart-lung transplants. Surgical experience directly impacts long-term survival rates.
Patient Consensus: Patients note that primary treatment often focuses on medication like sildenafil. Surgery is reserved for structural defects or end-stage transplants. Those undergoing ASD closure in India report excellent results. Underlying hypertension typically resolves within a year of the procedure.
Pulmonary hypertension is generally a chronic, progressive condition without a complete cure. However, specialised centres in India offer pulmonary thromboendarterectomy (PTE). This surgery can potentially cure Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Other treatments focus on reducing pressure and improving heart function through medication or transplants.
Bookimed Expert Insight: India excels in high-volume organ transplants, with Global Hospital Chennai performing over 1,000 liver transplants. This surgical depth often translates to better outcomes for those needing complex heart or lung transplants. Patients benefit from this extensive expertise in managing the most severe, late-stage arterial pressure cases.
Patient Consensus: Treatment aims to lower arterial pressure and restore heart size rather than achieving a full cure. Patients in India note that severe cases often need three simultaneous medications. They also require strict low-salt diets to maintain long-term stability.
India hosts several high-volume centres for pulmonary hypertension treatment. Top institutions include Global Hospital Chennai and Medanta Hospital. They provide multidisciplinary cardiac and pulmonary care. These facilities hold JCI or NABH accreditations. They offer diagnostics like heart catheterisation and specialised transplant services.
Bookimed Expert Insight: Many hospitals have cardiac units. But Global Hospital Chennai stands out for its experience in rare, combined heart-lung transplants. This suggests a higher level of intensive care and surgical coordination. This is essential for patients with advanced stage-4 pulmonary hypertension. They may require late-stage interventions.
Patient Consensus: Patients emphasise that a right-heart catheterisation is essential to confirm diagnosis over simple scans. When medication no longer works, patients often need complex heart-lung transplants. They prefer centres in Chennai or Pune.
Advanced treatment for pulmonary hypertension in India includes targeted drug therapies, complex heart-lung transplants, and catheter-based procedures. These include balloon pulmonary angioplasty. Leading centres in New Delhi, Gurgaon, and Chennai provide multidimensional care for chronic thromboembolic and arterial hypertension. They use JCI-standard facilities.
Bookimed Expert Insight: India has emerged as a leader in complex organ transplants. Global Hospital Chennai was the first in the country to perform minimally invasive lung transplants. Medical therapy is standard. However, surgeons at specialised centres like Medanta Hospital handle high-risk cases where heart function has dropped below 30%.
Patient Consensus: Patients emphasise that a right heart catheterisation at a major centre is essential. It helps ensure a correct diagnosis. They often find that combining oral medications with dedicated pulmonary rehabilitation helps. This maintains daily function in India.
Typical pulmonary hypertension treatment in India involves lifelong management rather than a short-term course. Diagnostic procedures like right heart catheterisation take 1 to 2 days. Procedural hospital stays last several days. However, medication regimens for this chronic condition continue indefinitely to manage symptoms.
Bookimed Expert Insight: Indian centres like Global Hospital Chennai specialise in lung transplants, which are critical for severe cases. Large networks like Manipal Hospitals handle 2,000,000 patients annually and often provide free airport transfers for international visitors. This high volume allows Indian specialists to manage complex cases that require lifelong monitoring protocols.
Patient Consensus: Patients highlight that right heart catheterisation is the only way to confirm diagnosis before starting medication. Australians should plan for 24/7 therapy management in India, as standard treatments often involve continuous triple therapy or IV infusions.
Generic medicines for pulmonary hypertension are widely available in India through licensed pharmaceutical manufacturers. Patients can access affordable generic versions of sildenafil, tadalafil, bosentan, and ambrisentan. These formulations significantly reduce treatment costs for Australians compared to branded medications. They contain the same active therapeutic ingredients.
Bookimed Expert Insight: India ranks 7th globally in medical requests on the Bookimed platform. Major networks like Manipal Hospitals serve 2 million international patients annually across 15 locations. This high volume across diverse specialities suggests deep experience. Clinics manage complex pharmaceutical logistics for international patients. Global Hospital Mumbai reports treatment costs are often 30% to 50% lower than in Europe.
Patient Consensus: Patients note that Indian patent laws allow rapid generic production once original patents expire. Practical experience shows sourcing from licensed pharmacies like Jan Aushadhi Kendras ensures quality and affordability. People emphasise that generic sildenafil is far cheaper than branded versions. Many advise patients to check for a Certificate of Analysis before purchase. This confirms the medication's legitimacy.